Diagnostics, ELISA kits
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
325
NCT05496595
DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 26, 2022
Completion: Feb 5, 2024
NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Start: Jun 28, 2023
Completion: Dec 31, 2026
Loading map...